Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 63.64% vs 42.11% in Sep 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
Compare Quarterly Results Of NovaBay Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 16,839.39% vs -6.45% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 63.64% vs 42.11% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 84.62% vs -62.50% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






